Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro.
Feelders RA, Lamberts SW, Hofland LJ, van Koetsveld PM, Verhoef-Post M, Themmen AP, de Jong FH, Bonjer HJ, Clark AJ, van der Lely AJ, de Herder WW. Feelders RA, et al. Among authors: de jong fh, de herder ww. J Clin Endocrinol Metab. 2003 Jan;88(1):230-7. doi: 10.1210/jc.2002-020621. J Clin Endocrinol Metab. 2003. PMID: 12519858 Free article.
Octreoscan radioreceptor imaging.
van der Lely AJ, de Herder WW, Krenning EP, Kwekkeboom DJ. van der Lely AJ, et al. Among authors: de herder ww. Endocrine. 2003 Apr;20(3):307-11. doi: 10.1385/ENDO:20:3:307. Endocrine. 2003. PMID: 12721512 Review.
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.
van der Hoek J, de Herder WW, Feelders RA, van der Lely AJ, Uitterlinden P, Boerlin V, Bruns C, Poon KW, Lewis I, Weckbecker G, Krahnke T, Hofland LJ, Lamberts SW. van der Hoek J, et al. Among authors: de herder ww. J Clin Endocrinol Metab. 2004 Feb;89(2):638-45. doi: 10.1210/jc.2003-031052. J Clin Endocrinol Metab. 2004. PMID: 14764775 Free article. Clinical Trial.
The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ, van der Hoek J, van Koetsveld PM, de Herder WW, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, Feelders R, van der Lely AJ, Beckers A, Lamberts SW. Hofland LJ, et al. Among authors: de herder ww. J Clin Endocrinol Metab. 2004 Apr;89(4):1577-85. doi: 10.1210/jc.2003-031344. J Clin Endocrinol Metab. 2004. PMID: 15070915 Free article.
The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
Hofland LJ, van der Hoek J, Feelders R, van Aken MO, van Koetsveld PM, Waaijers M, Sprij-Mooij D, Bruns C, Weckbecker G, de Herder WW, Beckers A, Lamberts SW. Hofland LJ, et al. Among authors: de herder ww. Eur J Endocrinol. 2005 Apr;152(4):645-54. doi: 10.1530/eje.1.01876. Eur J Endocrinol. 2005. PMID: 15817922 Free article.
The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
van der Hoek J, van der Lelij AJ, Feelders RA, de Herder WW, Uitterlinden P, Poon KW, Boerlin V, Lewis I, Krahnke T, Hofland LJ, Lamberts SW. van der Hoek J, et al. Among authors: de herder ww. Clin Endocrinol (Oxf). 2005 Aug;63(2):176-84. doi: 10.1111/j.1365-2265.2005.02322.x. Clin Endocrinol (Oxf). 2005. PMID: 16060911 Clinical Trial.
475 results